Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis

International Journal of Impotence Research volume 16, pages 369–381 (2004)Cite this article

Abstract

The aim of this systematic review and meta-analysis is to evaluate whether the design and methodology of drug-treatment studies of premature ejaculation affect the efficacy outcome differently. Therefore, methodological, design and efficacy data from 79 studies (3034 males), published between 1943 and 2003, are reviewed. A meta-analysis is performed on 43 selective serotonin reuptake inhibitors (SSRIs) and clomipramine studies (1514 males), published between 1973 and 2003; these studies were pooled to provide a summary variance-weighted effect size. The antidepressant-induced percentage increase of the intravaginal ejaculation latency time (IELT) was calculated and examined against various methodological items. A significant difference in efficacy between SSRIs was observed. Using daily treatment, paroxetine appeared more effective than the other SSRIs. Retrospective use of a questionnaire, subjective reports, single-blind and open study designs generate far greater variability of ejaculation time both at baseline and during active drug treatment than real time assessment by stopwatch. In conclusion, at daily treatment, the overall efficacy of paroxetine, clomipramine, sertraline and fluoxetine is comparable, but paroxetine exerts the strongest ejaculation delay. Only eight (18.5%) studies on antidepressant treatment fulfilled all criteria used in evidence-based medicine, for example, randomised, double-blind studies with prospective real time (stopwatch) assessment of the IELT at each intercourse. Single-blind studies, open designs, retrospective reporting, or the use of a questionnaire to assess ejaculation time should be avoided.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Waldinger MD . The neurobiological approach to premature ejaculation (review article). J Urol 2002; 168: 2359–2367.

    Article  PubMed  Google Scholar 

  2. Waldinger MD, Olivier B . Selective serotonin reuptake inhibitors (SSRIs) and sexual side effects: differences in delaying ejaculation. In: Sacchetti E, Spano P (eds) Advances in Preclinical and Clinical Psychiatry, Vol I: Fluvoxamine: Established and Emerging Roles in Psychiatric Disorders. Excerpta Medica: Milan, Italy, 2000, pp 117–130.

    Google Scholar 

  3. Waldinger MD . Chapter 15: Rapid ejaculation. In: Levine SB, Risen CB, Althof SE (eds) Handbook of Clinical Sexuality for Mental Health Professionals. Brunner-Routledge: New York, 2003, pp 257–274.

    Google Scholar 

  4. Waldinger MD et al. The SSRIs fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 2001; 160: 283–289.

    Article  CAS  Google Scholar 

  5. Waldinger MD et al. Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111–118.

    Article  CAS  PubMed  Google Scholar 

  6. Waldinger MD, Olivier B . Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13(Suppl 6): S27–S33.

    Article  PubMed  Google Scholar 

  7. Olivier B, van Oorschot R, Waldinger MD . Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998; 13(Suppl 6): S9–S14.

    Article  PubMed  Google Scholar 

  8. Waldinger MD et al. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998; 8: 37–40.

    Article  CAS  PubMed  Google Scholar 

  9. Waldinger MD . Lifelong premature ejaculation: from authority based to evidence based medicine. Br J Urol Int, 2004 (in press).

  10. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B . An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract 1998; 2: 287–293.

    Article  CAS  PubMed  Google Scholar 

  11. Waldinger MD . Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impot Res 2003; 15: 309–313.

    Article  CAS  Google Scholar 

  12. Moser A . Die Verwendung von Nupercainal in Geburtshilfe, Gynakologie und Eheberatung (German). Wien Med Wochnschr 1953; 103: 814–816.

    CAS  Google Scholar 

  13. Schöning FW . Behandlungsergebnisse bei Ejakulatio praecox mit opipramol (Insidon) (German). Z Haut-Geschl Kr 1972; 47: 135–140.

    Google Scholar 

  14. Wiederholt I . Behandlung der Ejaculatio Praecox mit einem Antiandrogen. (German). Psychiat Prax 1977; 4: 176–180.

    CAS  Google Scholar 

  15. Porto R . Essai en double aveugle de la clomipramine dans léjaculation premature (French). Med Hygiene 1981; 39: 1249–1253.

    Google Scholar 

  16. Nielsen NP . L' ejaculazione precoce e il suo trattamento: nota preliminare sull'attivita' del caroxazone (Italian). Rass Studi Psichiatr 1981; 70: 1065–1080.

    Google Scholar 

  17. Giammusso B, Morgia G, Spampinato A, Motta M . La paroxetina nel trattamento dell'eiaculazione precoce. Arch Ital Urol Androl 1997; 69: 11–13.

    CAS  PubMed  Google Scholar 

  18. Beretta G et al. Trattamento con un alfa-bloccante (fenossibenzamina) della eiaculazione precoce (Italian). Minerva Urol Nefrol 1988; 40: 29–32.

    CAS  PubMed  Google Scholar 

  19. Martinez Hurtado M, Gonzales Menendez R, Idelfonso Alavarez E, Goicolea Maiza S . La eyaculacion precoz: caracteristicas clinicas y respuesta al tratamiento con guanetidina (Spanish). Rev Hosp Psiquiatr Habana 1981; 22: 105–116.

    Google Scholar 

  20. Pico Costero J, Abreu de la Torre C, Roque Banos YL . Eyaculacion precoz. Tratamiento con tioridacina (Spanish). Rev Hosp Psiquiatr Habana 1986; 27: 277–280.

    Google Scholar 

  21. De Almeida Claro J et al. Experiencia brasileira com a trazodona no tratamento da ejaculacao precoce (Portugese). Rev Brasil Med 2000; 57: 931–934.

    Google Scholar 

  22. Hronek J, Kolomaznik M . Farmakoterapie prekotneho prubehu pohlavniho styku. (Czech). Cesk Psychiatr 1986; 82: 303–306.

    CAS  PubMed  Google Scholar 

  23. Kolomaznik M, Hronek J, Kolomaznik J, Kufner P . Sertralin v leche ejaculatio praecox: Intermitentne nebo kontinualne? (Czech). Psychiatr C'slo 1998; 2: 244–246.

    Google Scholar 

  24. Kolomaznik M et al. Fluoxetin v lecbe ejaculatio praecox (Czech). Psychiatrie 2002; 6: 6–9.

    Google Scholar 

  25. Kery S, Kozma A . Ejaculatio praecox citalopram kezelese (Hungarian). Magyar Urol 1995; 7: 359–364.

    Google Scholar 

  26. Choi HK, Xin ZC, Cho IR . The effect of herb cream (SS-cream) on premature ejaculation. J Korean Androl Soc 1993; 11: 99–105.

    Google Scholar 

  27. Xin ZC, Seong DH, Minn YG, Choi HK . A double blind clinical trial of SS-cream on premature ejaculation. Korean J Urol 1994; 35: 533–537.

    Google Scholar 

  28. Bishop YMM . The δ-method for calculating asymptomatic distributions. In: Bishop YMM, Fienberg SE, Holland PW (eds). Discrete Multivariate Analysis: Theory and Practice. The MIT Press: Cambridge, MA, and London, England, 1975, pp 486–502.

    Google Scholar 

  29. Schapiro B . Premature ejaculation, a review of 1130 cases. J Urol 1943; 50: 374–379.

    Article  Google Scholar 

  30. Aycock L . The medical management of premature ejaculation. J Urol 1949; 62: 361–362.

    Article  CAS  PubMed  Google Scholar 

  31. Damrau F . Premature ejaculation: use of ethyl aminobenzoate to prolong coitus. J Urol 1963; 89: 936–939.

    Article  CAS  PubMed  Google Scholar 

  32. Berkovitch M, Keresteci AG, Koren G . Efficacy of prilocaine–lidocaine cream in the treatment of premature ejaculation. J Urol 1995; 154: 1360–1361.

    Article  CAS  PubMed  Google Scholar 

  33. Xin ZC, Choi YD, Lee SH, Choi HK . Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies. Yonsei Med J 1997; 38: 91–95.

    Article  CAS  PubMed  Google Scholar 

  34. Choi HK et al. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomised, placebo controlled clinical study. Int J Impot Res 1999; 11: 261–264.

    Article  CAS  PubMed  Google Scholar 

  35. Choi HK et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000; 55: 257–261.

    Article  CAS  PubMed  Google Scholar 

  36. Slob AK, van Berkel A, van der Werff ten Bosch JJ . Premature ejaculation treated by local penile anaesthesia in an uncontrolled clinical replication study. J Sex Res 2000; 37: 244–247.

    Article  Google Scholar 

  37. Atikeler MK, Gecit I, Senol FA . Optimum usage of prilocaine–lidocaine cream in premature ejaculation. Andrologia 2002; 34: 356–359.

    Article  CAS  PubMed  Google Scholar 

  38. Bartova D, Bouchal M . Thioridazine treatment of ejaculatio praecox. Act Nerv Super (Praha) 1965; 7: 244–245.

    CAS  Google Scholar 

  39. Mellgren A . Treatment of ejaculatio praecox with thioridazine. Psychother Psychosom 1967; 15: 454–460.

    Article  Google Scholar 

  40. Falaschi P et al. Brain dopamine and premature ejaculation: results of treatment with dopamine antagonists. In: Gessa GL, Corsini GU (eds) Apomorphine and Other Dopaminomimetics. Vol. 1: Basic Pharmacology. Raven Press: New York, 1981, pp 117–121.

    Google Scholar 

  41. Wabrek AJ . Effect of metoclopramine on ejaculatory threshold in a group of premature ejaculators. Neurourol Urodyn 1984; 3: 155–161.

    Article  Google Scholar 

  42. Greco E, Polonio-Balbi P, Speranza JC . Levosulpiride: a new solution for premature ejaculation. Int J Impot Res 2002; 14: 308–309.

    Article  CAS  PubMed  Google Scholar 

  43. Bennett D . Treatment of ejaculatio praecox with monoamine-oxidase inhibitors (letter). Lancet 1961; 9: 1309.

    Article  Google Scholar 

  44. Shilon M, Paz GF, Hommonai ZT . The use of phenoxybenzamine treatment in premature ejaculation. Fertil Steril 1984; 42: 659–661.

    Article  CAS  PubMed  Google Scholar 

  45. Beretta G, Chelo E, Fanciullacci F, Zanollo A . Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation. Acta Eur Fertil 1986; 17: 43–45.

    CAS  PubMed  Google Scholar 

  46. Cavallini G . Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol 1995; 28: 126–130.

    Article  CAS  PubMed  Google Scholar 

  47. Boneff AN . Topical treatment of chronic prostatitis and premature ejaculation. Int Urol Nephrol 1971; 4: 183–186.

    Article  Google Scholar 

  48. Brown AJ . Ciprofloxacin as cure of premature ejaculation (case report). J Sex Marital Ther 2000; 26: 351–352.

    Article  CAS  PubMed  Google Scholar 

  49. Cooper AJ, Magnus RV . A clinical trial of the beta blocker propranolol in premature ejaculation. J Psychosom Res 1984; 28: 331–336.

    Article  CAS  PubMed  Google Scholar 

  50. Segraves RT . Treatment of premature ejaculation with lorazepam (letter). Am J Psychiatry 1987; 144: 1240.

    CAS  PubMed  Google Scholar 

  51. Fein RL . Intracavernous medication for treatment of premature ejaculation. Urology 1990; 35: 301–303.

    Article  CAS  PubMed  Google Scholar 

  52. Eaton H . Clomipramine in the treatment of premature ejaculation. J Int Med Res 1973; 1: 432–434.

    Article  Google Scholar 

  53. Goodman RE . An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res Suppl 1980; 3: 53–59.

    Google Scholar 

  54. Girgis SM, El-Haggen S, El-Hermouzy S . A double-blind trial of clomipramine in premature ejaculation. Andrologia 1982; 14: 364–368.

    Article  CAS  PubMed  Google Scholar 

  55. Assalian P . Clomipramine in the treatment of premature ejaculation. J Sex Res 1988; 24: 213–215.

    Article  CAS  PubMed  Google Scholar 

  56. Waldinger MD, Hengeveld MW, Zwinderman AH . Paroxetine treatment of premature ejaculation: a double-blind, randomised, placebo-controlled study. Am J Psychiatry 1994; 151: 1377–1379.

    Article  CAS  PubMed  Google Scholar 

  57. Althof SE et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402–407.

    CAS  PubMed  Google Scholar 

  58. Mendels J, Camera A, Sikes C . Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995; 15: 341–346.

    Article  CAS  PubMed  Google Scholar 

  59. Montorsi F et al. Clomipramine for premature ejaculation: a randomized, double blind, placebo controlled study. Acta Urol Ital 1995; 1: 5–6.

    Google Scholar 

  60. Kara H et al. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind, placebo controlled study. J Urol 1996; 156: 1631–1632.

    Article  CAS  PubMed  Google Scholar 

  61. Ludovico GM et al. Paroxetine in the treatment of premature ejaculation. Br J Urol 1996; 78: 881–882.

    Article  Google Scholar 

  62. Lee HS, Song DH, Kim CH, Choi HK . An open clinical trial of fluoxetine in the treatment of premature ejaculation. J Clin Psychopharmacol 1996; 16: 379–382.

    Article  CAS  PubMed  Google Scholar 

  63. Waldinger MD, Hengeveld MW, Zwinderman AH . Ejaculation retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomised, dose–response study. Br J Urol 1997; 79: 592–595.

    Article  CAS  PubMed  Google Scholar 

  64. Raju GAR et al. Evaluation of fluoxetine in premature ejaculation. Indian J Pharmacol 1997; 29: 204–205.

    CAS  Google Scholar 

  65. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B . Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998; 18: 274–281.

    Article  CAS  PubMed  Google Scholar 

  66. Haensel SM, Klem TMAL, Hop WCJ, Slob AK . Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J Clin Psychopharmacol 1998; 18: 72–77.

    Article  CAS  PubMed  Google Scholar 

  67. Biri H et al. Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study. Int Urol Nephrol 1998; 30: 611–615.

    Article  CAS  PubMed  Google Scholar 

  68. McMahon CG . Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998; 159: 1935–1938.

    Article  CAS  PubMed  Google Scholar 

  69. McMahon CG . Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Res 1998; 10: 181–184.

    Article  CAS  PubMed  Google Scholar 

  70. Kim SC, Seo KK . Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998; 159: 425–427.

    Article  CAS  PubMed  Google Scholar 

  71. Balbay MD et al. Treatment of premature ejaculation with sertralin. Int Urol Nephrol 1998; 30: 81–83.

    Article  CAS  PubMed  Google Scholar 

  72. Basar MM et al. Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol 1999; 52: 1.008–1.011.

    Google Scholar 

  73. Yilmaz U et al. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. J Urol 1999; 161: 107–111.

    Article  CAS  PubMed  Google Scholar 

  74. McMahon CG, Touma K . Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 1999; 11: 241–245.

    Article  CAS  PubMed  Google Scholar 

  75. Atan A, Basar MM, Aydoganli L . Comparison of the efficacy of fluoxetine alone vs fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Arch Esp Urol 2000; 53: 856–858.

    CAS  PubMed  Google Scholar 

  76. Rowland DL, De Gouveia Brazao CA, Slob AK . Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective. BJU Int 2001; 87: 357–360.

    Article  CAS  PubMed  Google Scholar 

  77. Waldinger MD, Zwinderman AH, Olivier B . Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 2001; 21: 293–297.

    Article  CAS  PubMed  Google Scholar 

  78. Waldinger MD, Zwinderman AH, Olivier B . SSRIs and ejaculation: a double-blind, randomised, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21: 556–560.

    Article  CAS  PubMed  Google Scholar 

  79. Waldinger MD, Zwinderman AH, Olivier B . Antidepressants and ejaculation: a double-blind, randomised, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003; 23: 467–470.

    Article  CAS  PubMed  Google Scholar 

  80. Novaretti JPT, Pompeo ACL, Arap S . Selective serotonin uptake inhibitor in the treatment of premature ejaculation. Brazil J Urol 2002; 28: 116–122.

    Google Scholar 

  81. Atmaca M, Kuloglu M, Tezcan E, Semercioz A . The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res 2002; 14: 502–505.

    Article  CAS  PubMed  Google Scholar 

  82. Segraves RT, Saran A, Segraves K, Maguire E . Clomipramine vs placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther 1993; 19: 198–200.

    Article  CAS  PubMed  Google Scholar 

  83. Haensel SM, Rowland DL, Kallan KTHK, Slob AK . Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996; 156: 1310–1315.

    Article  CAS  PubMed  Google Scholar 

  84. Strassberg DS et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999; 25: 89–101.

    Article  CAS  PubMed  Google Scholar 

  85. Kim SW, Paick J-S . Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology 1999; 54: 544–547.

    Article  CAS  PubMed  Google Scholar 

  86. McMahon C, Touma K . Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind, placebo-controlled, crossover studies. J Urol 1999; 161: 1826–1830.

    Article  CAS  PubMed  Google Scholar 

  87. Abdel-Hamid IA, El Naggar EA, El Gilany AH . Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001; 13: 41–45.

    Article  CAS  PubMed  Google Scholar 

  88. Chia SJ . Management of premature ejaculation – a comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002; 25: 301–305.

    Article  PubMed  Google Scholar 

  89. Salonia A et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002; 168: 2486–2489.

    Article  CAS  PubMed  Google Scholar 

  90. Riley AJ, Riley EJ . Amitriptyline-perphenazine and the squeeze technique in premature ejaculation. J Pharmacother 1979; 2: 136–140.

    Google Scholar 

  91. Xin ZC et al. Penile sensitivity in patients with primary premature ejaculation. J Urol 1996; 156: 979–981.

    Article  CAS  PubMed  Google Scholar 

  92. Xin ZC, Choi YD, Rha KH, Choi HK . Somatosensory evoked potentials in patients with premature ejaculation. J Urol 1997; 158: 451–455.

    Article  CAS  PubMed  Google Scholar 

  93. Truitt WA, Coolen LM . Identification of a potential ejaculation generator in the spinal cord. Science 2002; 297: 1566–1569.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Neurosexology, Leyenburg Hospital, The Hague, The Netherlands

    M D Waldinger

  2. Department of Psychopharmacology, Utrecht Institute for Pharmaceutical Sciences and Rudolf Magnus Institute for Neurosciences, Faculty of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands

    M D Waldinger & B Olivier

  3. Department of Medical Statistics, Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    A H Zwinderman

  4. Department of Internal Medicine and Endocrinology, Reinier de Graaf Groep, Delft-Voorburg, The Netherlands

    D H Schweitzer

  5. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

    B Olivier

Authors
  1. M D Waldinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A H Zwinderman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D H Schweitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Olivier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M D Waldinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waldinger, M., Zwinderman, A., Schweitzer, D. et al. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16, 369–381 (2004). https://doi.org/10.1038/sj.ijir.3901172

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901172

Keywords

This article is cited by

Search

Advanced search

Quick links